PennyStockPayCheck.com Rss

Featured Posts

Chase Bank Limits Cash Withdrawals, Bans International... Before you read this report, remember to sign up to http://pennystockpaycheck.com for 100% free stock alerts Chase Bank has moved to limit cash withdrawals while banning business customers from sending...

Read more

Richemont chairman Johann Rupert to take 'grey gap... Billionaire 62-year-old to take 12 months off from Cartier and Montblanc luxury goods groupRichemont's chairman and founder Johann Rupert is to take a year off from September, leaving management of the...

Read more

Cambodia: aftermath of fatal shoe factory collapse... Workers clear rubble following the collapse of a shoe factory in Kampong Speu, Cambodia, on Thursday

Read more

Spate of recent shock departures by 50-something CEOs While the rising financial rewards of running a modern multinational have been well publicised, executive recruiters say the pressures of the job have also been ratcheted upOn approaching his 60th birthday...

Read more

UK Uncut loses legal challenge over Goldman Sachs tax... While judge agreed the deal was 'not a glorious episode in the history of the Revenue', he ruled it was not unlawfulCampaign group UK Uncut Legal Action has lost its high court challenge over the legality...

Read more

Russell Breweries Inc. Announces Purchase of 68,000 Class A Exchangeable Non-Voting Preferred Shares in the Capital of Russell Brewing Company Ltd.

Category : Stocks

VANCOUVER, BRITISH COLUMBIA–(Marketwired – April 5, 2013) - Russell Breweries Inc. (TSX VENTURE:RB) (the “Company“) announces that, pursuant to an exchange agreement (the “Exchange Agreement“) dated for reference as of March 31, 2008, between the Company, Russell Brewing Company Ltd. (“Subco“), and holders (the “Investors“) of Class A Exchangeable Non-Voting Preferred Shares (the “Exchangeable Shares“) in the capital of Subco, the Company has exercised its right (the “Exchange Right“) to purchase the Exchangeable Shares from the Investors. The Company is entitled to exercise the Exchange Right and purchase the Exchangeable Shares without any further action required on the part of the Investors.

See original here: Russell Breweries Inc. Announces Purchase of 68,000 Class A Exchangeable Non-Voting Preferred Shares in the Capital of Russell Brewing Company Ltd.

Post to Twitter

Shire Pharmaceuticals boss steps down, as AstraZeneca rues loss of exclusivity

Category : Business

News of Angus Russell’s departure comes as Britain’s second-largest drugmaker reports a 19% slide in third-quarter sales

The boss of Shire Pharmaceuticals, Angus Russell, is stepping down next April after five years at the helm and will be replaced by a senior Bayer executive.

Russell, 56, will leave at the annual meeting after 13 years with the drugs manufacturer, during which he turned the company from a small specialist firm into a FTSE 100 company, focused on attention deficit hyperactivity disorder medicines, a lucrative market in the US. Having spent 32 years in the pharmaceutical industry, including at AstraZeneca and ICI, he said he now wanted to spend more time with his family, as well as pursue his charitable interests and non-executive directorships. He got married for the second time last year, leaving him with responsibility for four young children.

Russell will be replaced by Flemming Ornskov, chief marketing officer of Bayer’s speciality pharmaceuticals business with sales of more than €10bn in Europe, China and the US. “He has impressed investors in this role, where he was responsible for the rollout of [blood-thinning pill] Xarelto,” said analysts at JP Morgan Cazenove. Ornskov previously worked for Merck and Novartis, as well as biotech firms.

Analysts at Cowen were surprised by Russell’s departure, noting: “The explanation given is the business is expanding further and more aggressively into international markets in which Ornskov has significant experience. This appears to be sound rationale.”

The news came as Shire’s third-quarter sales growth disappointed due to a cut-price version of one of its top-selling ADHD drugs coming onto the market. Missing analysts’ expectations, sales at Shire grew by 4% to $1.1bn. Sales of Adderall XR dropped 32% to $102m, which partially offset the 24% rise in sales of Shire’s new lead product Vyvanse to $247m. The drug will be called Elvanse when it is launched in Europe.

Mick Cooper, analyst at Edison Investment Research, said: “Shire’s growth has slowed because of generic competition to Adderall XR showing that it does face some of the issues facing big pharma. However the underlying growth remains strong and Angus Russell will be leaving Shire in a very strong position.”

Patent expiry on best-selling medicines also continues to haunt AstraZeneca, Britain’s second-largest drugmaker, which reported a 19% slide in third-quarter sales.

The company said it was hurt by the loss of exclusivity for Seroquel IR, its blockbuster antipsychotic treatment, as well as high blood pressure drug Atacand, antibiotic Merrem, cholesterol drug Crestor in Canada and heartburn pill Nexium in Europe. Revenues fell to $6.7bn (£4.15bn) in the third quarter from $8.2bn a year ago.

New chief executive Pascal Soriot, who joined from Roche and suspended share buybacks on his first day in the job, said buying in new treatments would be an important way of rebuilding the pipeline. He added that the recently launched heart drug Brilinta had the potential to do “far better”, admitting that AstraZeneca had failed to make the most of it.

The Frenchman replaced David Brennan, who was ousted by shareholders in the spring amid growing concern about AstraZeneca’s thin pipeline of new drugs. Soriot said his priority was to “restore the company to growth and scientific leadership” and promised to unveil the results of a strategy review to investors at the end of January.

The decision to halt share buybacks is seen as a sign that AstraZeneca is on the prowl for mid-sized to larger acquisitions, with speculation circling around UK group Shire and US firm Forest Laboratories.

“AstraZeneca’s key issue remains its shrinking sales line … impacted heavily by generic losses and with little offset from new products,” said Mark Clark at Deutsche Bank.

“The results, in our view, appear to put the company on track only to meet the bottom end of its guidance for a low-to-mid teens sales decline for the year and to deliver core earnings per share in the lower half of its $6-6.30 guidance range. This is of little consequence, however, given the overriding importance of the strategy review which is expected to be unveiled in early 2013.

Russell Means as a Conservative Bogeyman – Lew Rockwell (blog)

Category : Stocks

Russell Means as a Conservative Bogeyman
Lew Rockwell (blog)
All Russell Means ever really wanted for the Sioux was for them to be left alone by the feds. For this, he was targeted by various right-wing groups. For example, back in the 1970s, The John Birch Society bankrolled a speakers tour for one Douglass Durham,

and more

Herald editor-in-chief steps down

Category : Business, World News

The editor-in-chief of The Herald newspaper, Jonathan Russell, is to leave the media group at the end of this month.

Read more: Herald editor-in-chief steps down

Post to Twitter

Russell Emerging Markets Index Posted 8.1% Gain in Third Quarter of 2012

Category : World News

SEATTLE, WA–(Marketwire – Oct 3, 2012) – The Russell Emerging Markets Index reflected a return of 8.1% in the third quarter of 2012, outperforming the U.S. large-cap Russell 1000® Index by almost 2%. Year-to-date, both indexes have posted strong returns, with U.S. large caps (16.3%) outperforming emerging markets (12.8%) by approximately 3.5% through September 28, 2012.

Read the original post: Russell Emerging Markets Index Posted 8.1% Gain in Third Quarter of 2012

Post to Twitter

Asian Defensive Stocks Outperformed Their Dynamic Counterparts YTD in 2012 as of September 10th as Measured by the Russell Asia Pacific Index

Category : Stocks

SEATTLE, WA–(Marketwire – Sep 13, 2012) – The Russell Asia Pacific Defensive Index returned +11.0% for the year-to-date as of September 10th, compared to a +4.4% return for the Russell Asia Pacific Dynamic Index for the same time period.

More here: Asian Defensive Stocks Outperformed Their Dynamic Counterparts YTD in 2012 as of September 10th as Measured by the Russell Asia Pacific Index

Post to Twitter

Four of the Five ASEAN Country Constituents in the Russell Asia-Pacific Index Outperformed the Index YTD as of September 3rd

Category : Stocks

SEATTLE, WA–(Marketwire – Sep 6, 2012) – Four of the five ASEAN (association of southeast asian nations) country constituents in the Russell Asia-Pacific Index outperformed the Index year-to-date as of September 3rd, 2012.

Read the original here: Four of the Five ASEAN Country Constituents in the Russell Asia-Pacific Index Outperformed the Index YTD as of September 3rd

Post to Twitter

Russell Indexes: Asia Underperformed Europe & US YTD as of 8/21; All Global Regions Positive

Category : World News

SEATTLE, WA–(Marketwire – Aug 23, 2012) –  The Russell Asia-Pacific Index returned +8.7% year-to-date as of August 21st, relative to a +10.8% return for the Russell Developed Europe Index and a +13.8% return for the Russell 1000® Index for the same time period.

Continue reading here: Russell Indexes: Asia Underperformed Europe & US YTD as of 8/21; All Global Regions Positive

Post to Twitter

PFGBest chief arrested, admits 20-yr fraud, FBI says – Reuters

Category : Stocks


USA TODAY
PFGBest chief arrested, admits 20-yr fraud, FBI says
Reuters
* Russell Wasendorf Sr arrested for lying to regulators * Admitted to 20 years of fraud in suicide note * Federal complaint alleges false statements from 2010-2012 By Tom Polansek and Ann Saphir CHICAGO, July 13 (Reuters) – Russell Wasendorf Sr was
Peregrine CEO ArrestedWall Street Journal
PFG founder Wasendorf arrested in fraud caseCNN
Peregrine founder's suicide note details fraudFinancial Times
Los Angeles Times

Post to Twitter

The Russell Greater China Index Returned +2.7% Year-to-Date as of June 12th

Category : World News

SEATTLE, WA–(Marketwire – Jun 15, 2012) – The Russell Greater China Index has returned +2.7% year-to-date as of June 12th, as compared to a +0.7% return for the Russell Asia-Pacific Index for the same time period.

View original post here: The Russell Greater China Index Returned +2.7% Year-to-Date as of June 12th

Post to Twitter